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Background: Urinary stones are affecting more children, and pediatric stone formers
have unique pathophysiology compared to adults. While adult stone formers are most
frequently male, children have an age dependent sex prevalence. Under 10 years, a
majority of stone formers are boys; adolescent stone formers are mostly female. Previous
adult studies have shown that stone composition is influenced by the sex and age of the
stone former. Thus, we hypothesize that female and male stone forming children will also
have sex and age specific stone phenotypes.
Methods: Retrospective chart review of a large pediatric center’s stone forming children
6/1/2009 to 6/1/2016. Patients were identified by ICD 9 codes: N20, N20.1, and N20.9.
Charts were reviewed for radiographic evidence of stones or documented visualized
stone passage.
Results: One hundred and thirty six subjects: 54 males and 82 females. Females were
older, median age 14 years [interquartile range (IQR): 11, 15] vs. males’ median age 12
years (IQR: 11, 14) (p < 0.01). Females had lower height z-scores, median 0.2 (IQR:
−0.8, 0.8) vs. males’ median 0.8 (IQR: −0.2, 1.8) (p < 0.01). Presenting symptoms were
similar except flank pain affecting 39% of females vs. 22% of males (p= 0.04). Leukocyte
esterase was positive in more females than males (33 vs. 4%) (p < 0.001). Males had a
higher BUN/Cr ratio, mean ± standard deviation of 19.8 ± 6.3 vs. 16.6 ± 6.5 in females
(p= 0.01). Glomerular hyperfiltration was present in 9% of patients while 35% of patients
had estimated glomerular filtration rate (eGFR)<90ml/min/1.73m2. Treatment strategies
and clinical course were similar except females were told to increase dietary citrate more
frequently than males (21 vs. 4%) (p < 0.01).
Conclusion: We have provided a novel analysis and demonstrated that low height
z-score and pyuria are more common in female stone formers. We have also shown
that 9% of pediatric stone formers have labs consistent with hyperfiltration. Whether
high protein intake and/or chronic dehydration are associated with hyperfiltration and
long-term renal function in children with kidney stones will be an area for future research.
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INTRODUCTION
Urinary stone disease is a frequent cause of morbidity in the
United States with approximately 10% of adults developing
a stone in their lifetime, and half of those affected will
have recurrent stones (1). Traditionally, urinary stones were
considered an adult disease. However, there is mounting evidence
for increased stone formation in the pediatric population, and
the number of children seen for urinary stone disease doubled
between 1997 and 2012 (2, 3). The monetary burden of stone
disease is also growing and adult stone care charges are now
10 billion dollars annually (4). Hospital costs/charges for stone
forming children are similarly increasing, and inpatient care in
2012 totaled $17.5 million, a 20% increase over 15 years after
adjusting for health care inflation and population growth (2).
The mechanisms driving increased stone formation in children
remains unknown; however, urinary stones now account for 1 in
685 pediatric admissions (5).
The adage that “children are not little adults” may be applied
to pediatric stone formers as they have a unique stone phenotype
compared to adults. Children are more likely than adults to have
specific metabolic derangements driving their stone formation
and also have lower rates of spontaneous stone passage (6, 7).
As a result children generally undergo a more comprehensive
metabolic work up compared to adults and are more likely
to require surgical intervention for their acute stone treatment
(8). In addition, pediatric stone formers have distinctive sex
prevalence patterns. While adults with stones are most frequently
male, pediatric stone formers have an age dependent sex
prevalence (1, 2). Novak et al. (8) demonstrated that stone
forming children<10 years of age are more often male. However,
in the adolescent age range, girls form more stones than boys
(2, 8). Adolescent females also represent the largest proportion
of the pediatric stone forming population overall (2, 8). This
finding of age dependent sex prevalence and preponderance of
adolescent girls in the pediatric urinary stone population have
been replicated by other groups using the Healthcare Cost and
Utilization Project Kids’ Inpatient Database (2, 9). Furthermore,
adult stone formers have stone phenotypes that are influenced
by sex and age (10). Despite these studies, we have very limited
data describing stone risk factors, presentation, and management
differences between pediatric male and female stone patients.
Therefore, this retrospective analysis was performed to evaluate
a pediatric stone forming cohort for lithogenic risk factors and
descriptive patient characteristics while divided by sex. The
objective of this study was to define the urinary stone patient
epidemiology specific to female and male patients who were
evaluated at a single tertiary care children’s hospital.
MATERIALS AND METHODS
This is a retrospective review of all urinary stone patients
seen at Akron Children’s Hospital during a 7-year time period
(June 2009 to June 2016) and was approved by the Akron
Children’s Institutional Review board (1040501-5). All children
and adolescents ≤19 years of age who were treated for urinary
stones at Akron Children’s hospital were included. Patients
were identified by the following diagnostic codes: ICD 10: N20
(calculus of kidney), N20.1 (calculus of ureter), and N20.9
(urinary calculus, unspecified) and ICD9: 592 (calculus of kidney
and ureter), 592.1 (calculus of ureter), 592.9 (urinary calculus,
unspecified). After identification by ICD9 code, individual charts
were reviewed and patients without radiographic evidence of
stones or visualized stone passage confirmed by attending
physician documentation were excluded. The clinical data
obtained included: age, sex, height, weight (all recorded from
initial stone presentation), associated medical diagnoses, history
of skeletal fractures, medications, presenting symptoms, number
of stones, number of stone surgeries, number of emergency room
visits and hospital admissions related to urinary stones, number
and type of imaging related to urinary stones, requirement of
subspecialty care, medical interventions for stone, family history
of stones, serum chemistries, stone analysis, vitamin D, PTH,
urine studies (pH, specific gravity, blood, protein), 24 h urine
studies (urine Na, Ca, Ox, Phos, citrate), and stone analysis. The
height, weight and BMI were converted to z-scores by using CDC
defined normative values (https://www.cdc.gov/growthcharts/
percentile_data_files.htm). Subjects were then compared by sex,
females vs. males. Estimated glomerular filtration rate (eGFR)
was determined using the bedside Schwartz equation (11).
Data examination included calculation of full summary
statistics for continuous variables, as well as calculations of
frequencies and percentages for categorical variables. Continuous
data was evaluated for normality using the D’Agostino and
Pearson normality test. If data from both groups were normally
distributed the Welch’s t-test was used, if at least one group
had data that was not normally distributed the Mann-Whitney
test was used. For percentages, the Pearson Chi-square test was
used only if all excepted cell frequencies were ≥5, otherwise the
Fisher exact probability test was used. Graphpad PRISM was
used to analyze continuous data and perform linear regression
while VassarStats (http://vassarstats.net/) was used to compare
percentages (12). All testing was two- tailed and evaluated at the
Type I error rate of alpha= 0.05 level of statistical significance.
RESULTS
Patients
A total of 185 individual subjects were identified through ICD 9
diagnostic codes. Of these, 49 did not have radiographic evidence
of urinary stones and/or documented stone passage on chart
review and were excluded. Therefore, a total of 136 subjects were
analyzed in this study; these were subdivided into 54 males and
82 females.
Presentation
Patient presentation is detailed in Table 1. Female patients
were significantly older with median age 14 years (interquartile
range (IQR: 11, 15) vs. males with median 12 years (IQR: 11,
14) (p < 0.01). Females also had lower height z-scores with
median 0.2 (IQR: −0.8, 0.8) compared to males with median 0.8
(IQR: −0.2, 1.8) (p < 0.01). Five patients were identified with
congenital anomalies of the kidney and urinary tract including:
horseshoe kidney, neurogenic bladder with Mitrofanoff, duplex
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kidney, congenital renal dysplasia, and medullary sponge kidney.
Twenty-nine patients had dilation of the renal collecting system
on imaging. One patient was diagnosed with Renal tubular
acidosis (RTA) and one patient had cystinuria. No other
monogenic or genetic stone diagnoses were present nor did any
patients have formally diagnosed Rickets. Of note, two patients
had Crohn’s disease and one had Ulcerative Colitis. Presenting
symptoms were similar between the groups except for flank pain
which was described by 39% of female patients vs. only 22%
of male patients (p = 0.04). Male and female stone patients
had similar and very low rates of Furosemide and Topiramate
exposure (4 females and 2 males both accounting for 4% of
their respective populations). Both females and males had near
identical rates of reporting a family history of urinary stones
(65 and 64%, respectively) despite low rates of monogenic stone
disease.
Evaluation
The evaluation of urinary stone patients (Table 2) was similar
between male and female patients. Of note, CTs were obtained
more than twice as often as renal ultrasound (RUS) in both
male and female urinary stone formers; females: 67% CT vs.
28% RUS and males: 57% CT vs. 20% RUS. Serum basic
metabolic panels (BMP) and calcium levels were obtained in
approximately 75% of patients but serum phosphorous, uric
acid, PTH and vitamin D levels were obtained in <25% of both
males and females. Twenty-four hour urine stone risk panels
(Litholink Corporation, Chicago IL) were obtained in under half
of patients and Pediatric Urology referrals were more common
than Pediatric Nephrology referrals and only 20% of patients
were evaluated by a nephrologist.
Laboratory Results
Laboratory results for male and female pediatric stone formers
are presented in Table 3. Electrolytes were similar between the
sexes, but both the BUN and the BUN/Creatinine ratio were
higher in male patients. There were no significant differences in
24 h urine levels for calcium, volume, oxalate, citrate, calcium
oxalate supersaturation, or calcium phosphate supersaturation.
On urinalysis, over 3/4 of both males and females tested
positive for hemoglobin and just under 1/2 tested positive
for protein. Females had significantly higher rates of positive
leukocyte esterase (LE). Twenty-four hour urine stone risk
panels (Litholink Corporation, Chicago IL) showed no significant
differences between females and males for urinary stone risk
factors including citrate, calcium and oxalate levels (13–16). Of
13 urinary stones from females submitted for analysis, 9 (69%)
contained calcium oxalate (dihydrate), 7(54%) contained calcium
oxalate (monohydrate), 5 (38%) contained calcium phosphate
(apatite), 1(8%) contained calcium phosphate (brushite), and
1(8%) contained struvite. Of 10 urinary stones from males
submitted for analysis, 7(70%) contained calcium oxalate
(dihydrate), 5(50%) contained calcium oxalate (monohydrate),
1(10%) contained ammonium urate, 2(20%) contained calcium
phosphate (apatite).
Metabolic Workup Findings
Key findings onmetabolic evaluation are presented inTable 4. Of
the 11 females that had a height z-score<−1, six had concurrent
diagnosis that may explain their short stature including
one patient each with Crohn’s disease, chronic lymphocytic
thyroiditis, “hormone imbalance” and spastic quadriparesis along
with 2 patients with chronic kidney disease (CKD). Of the 2
boys with a score of < −1, one had growth hormone deficiency.
The most common finding on lab evaluation was low serum
bicarbonate (HCO−3 or CO2) which occurred in 23% of patients.
Elevated serum calcium and vitamin D levels were only identified
in 1 patient in each group. Glomerular hyperfiltration, defined
as an eGFR > 140 ml/min/1.73 m2 (17), was present in 9% of
patients while 35% of patients had a eGFR < 90 ml/min/1.73
m2. Of the 23 children who had an eGFR < 90 ml/min/1.73
m2, 10 had concurrent diagnosis that might explain this finding;
4 had known CKD, 3 had pyelonephritis, 2 had acute kidney
injury with pyelonephritis, 1 had proteinuria and 1 had had “an
elevated serum creatinine.” However, these labs were collected at
the time of a symptomatic stone episode and the eGFR calculated
for each patient may not be an accurate reflection of these
children’s true baseline eGFR. Hypercalciuria, hyperoxaluria, and
hypocitraturia were identified in 20, 33, and 2% of children,
respectively. There were no significant correlations of height z
score with eGFR, serum calcium or serum bicarbonate; there was
a trend toward correlation between increasing height z-score and
increasing serum calcium levels but did not reach significance
(p = 0.167) (Figure 1). eGFR significantly correlated with the
serum BUN/creatinine ratio, but not the serum bicarbonate
(Figure 2). The correlation between dietary markers of protein
intake and eGFR, BUN, and BUN/creatinine ratios are presented
in Figure 3.
Management and Outcomes
The clinical course, procedures, and treatment of pediatric stone
patients is presented in Table 5. Males and females had similar
rates of hospitalizations, multiple stone episodes, multiple ED
visits, and procedures. Pharmacological prevention of stones
was only provided to a minority of patients, with citrate or
thiazides each prescribed to ≤7% of males or females. Dietary
recommendations were documented as presented to just under
¾ of both male and female patients. Increased citrate intake was
recommended to significantly more females than male patients
(p= 0.01).
DISCUSSION
Urinary stone disease is increasing in children, and occurs with
a female to male excess of 2.3:1 (8). Female preponderance
among pediatric stone formers is distinct from adults and is
driven by poorly understood mechanisms. The primary object
of this paper was to determine if female pediatric urinary stone
formers had different clinical phenotypes compared to males.
Based upon our review of the literature, this has not previously
been directly measured. Males and females in our population
had similar stone risk profiles including urine oxalate, calcium,
and citrate levels. Family history of kidney stones was also
Frontiers in Pediatrics | www.frontiersin.org 3 February 2019 | Volume 7 | Article 32
Schwaderer et al. Female vs. Male Children With Stones
TABLE 1 | Presentation.
Female (n = 82) Male (n = 54) Statistical test P-value
Mean ± Std Dev Median (25, 75%) Mean ± Std Dev Median (25, 75%)
Age (years) 12.9 ± 2.8 14 (11,15) 11.7 ± 2.8 12 (11,14) Mann- Whitney *< 0.01
∧Height z-score −0.25 ± 1.80 0.17 (−0.8, 0.8) 0.73 ± 1.34 0.83 (−0.2, 1.8) Mann-Whitney *< 0.01
∧Weight z-score 0.67 ± 1.43 1.0 (−0.2, 1.7) 0.96 ± 1.61 0.9 (−0.5, 2.4) Mann- Whitney 0.60
∧BMI z-score 0.91 ± 1.16 1.1 (1.2, 1.8) 0.50 ± 1.60 0.3 (−1.0, 2.2) t-test 0.25
Number % Number %
Hematuria 12 15 9 17 Chi-square 0.75
Flank pain 32 39 12 22 Chi-square *0.04
Abd pain 44 54 32 59 Chi-square 0.52
Nausea 29 35 18 33 Chi square 0.80
Vomiting 28 34 12 22 Chi square 0.11
Fever 5 6 5 9 Fisher exact 0.52
Dysuria 8 10 6 11 Chi square 0.76
Back pain 12 15 7 13 Chi square 0.78
Dilated collecting system# 21 25 8 15 Chi square 0.13
Furosemide 2 2 2 4 Fisher exact 1.00
Topiramate 2 2 0 0 Fisher exact 0.52
Fracture hx without comorbidities 7 8.5 4 7.4 Chi square 0.82
Family hx of urinary stones 53 65 35 64 Chi square 1.00
∧The n for height, weight and BMI z-score was 49 females and 27 males, #hydronephrosis or pelvocaliectasis on CT or US. *Significant p-values are indicated in Bold.
TABLE 2 | Evaluation.
Outcome Female (n = 82) Male (n = 54) Statistical test P-value
Number % Number %
CT 55 67 31 57 Chi-square 0.25
US 23 28 11 20 Chi-square 0.21
X-ray 26 32 12 22 Chi-square 0.23
Serum BMP 63 77 44 81 Chi-square 0.51
Serum calcium 60 73 42 78 Chi-square 0.54
Serum phosphorous 15 18 13 24 Chi square 0.41
Serum uric acid 4 5 6 11 Fisher exact 0.19
Serum PTH 2 2 5 9 Fisher exact 0.11
Serum 25 Vitamin D 10 12 13 24 Chi square 0.07
24 h urine stone risk panel (Litholink) 30 37 25 46 Chi square 0.26
Stone analysis 13 16 10 19 Chi square 0.69
Pediatric Urology referral 57 70 37 69 Chi-square 0.89
Pediatric Nephrology referral 14 17 14 26 Chi-square 0.21
similar between groups. We did identify sex specific differences
between male and female stone patients, some of which were
novel. Specifically, female pediatric stone formers were older, had
lower height z-scores, were more likely to present with flank
pain, have positive leukocyte esterase in their urine and have
lower mean serum BUN/creatinine ratios. Although there was
no significant differences in kidney function between males and
females, we identified 9% of patients had eGFR measurements
consistent with glomerular hyperfiltration and that increasing
eGFR significantly correlates with increasing BUN/creatinine
ratios.
Several findings of this study were consistent with prior
literature including that females were significantly older than
males; this confirmed the high rates of urinary stone formation
in female adolescents as described by Dwyer et al. (18) and
Novak et al. (8). We also identified that ∼65% of stone forming
children had a family history of urinary stones, consistent with
Spivacow who demonstrated positive family history in 75% of
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TABLE 3 | Lab results.
Lab Normal Female (n = 82) n Male (n = 54) n Statistical test P-value
Mean ± Std Dev Median (25, 75%) Mean ± Std Dev Median (25, 75%)
Serum Na+ 133–145 138 ± 3 139 (137, 140) 63 139 (137±141) 138 ± 3 44 MW 0.94
Serum K+ 3.3–5.1 3.9 ± 0.6 3.9 (3.7, 4.1) 63 4.0 ± 0.9 4.0 (3.6, 4.2) 44 MW 0.49
Serum Cl− 96–108 105 ± 3 105 (103, 106) 63 105 ± 3 104 (103, 107) 44 t-test 0.58
Serum CO2 22–29 23.9 ± 2.5 23.9 (22.1, 26.1) 59 24.1 ± 3.0 24.0 (21.8, 26.7) 43 t-test 0.77
BUN 4–19 11.1 ± 4.2 10 (9, 13) 63 12.2 ± 2.7 12 (10, 14) 44 MW *0.02
Creatinine 0.4–1 0.83 ± 1.2 0.7 (0.6, 0.8) 63 0.67 ± 0.22 0.6 (0.5, 0.7) 44 MW 0.19
Serum BUN/creat 16.6 ± 6.5 16 (12, 20) 63 19.8 ± 6.3 19 (16, 24) 44 t-test *0.01
Serum Ca++ 7.6–11 9.32 ± 0.50 9.3 (9.0, 9.7) 60 9.35 ± 0.46 9.3 (9.0, 9.8) 42 MW 0.79
Serum Phos 2.7–4.5 4.3 ± 0.57 4.4 (4.1, 4.8) 15 4.4 ± 0.51 4.4 (4.1, 4.7) 13 t-test 0.77
Serum PTH 15–65 45.5 ± 31.8 45.5 (23, 68) 2 33.8 ± 18.5 34 (17.5, 50) 5 MW 0.57
Serum Vit D 20–50 26.4 ± 9.5 29.5 (18.5, 29.5) 10 28.9 ± 11.6 29 (20, 35) 13 MW 0.79
Uric acid 3–7 6.1 ± 1.7 6 (5, 8) 4 5.2 ± 1.5 5 (4, 7) 6 MW 0.26
Urine volume >1 0.96 ± 0.49 0.85 (0.58, 1.21) 30 1.02 ± 0.58 0.86 (0.59, 1.29) 25 MW 0.89
Urine Ca++ <4 2.87 ± 1.63 2.6 (1.6, 3.7) 30 3.36 ± 2.02 3.0 (2.1, 4.0) 25 MW 0.41
Urine Cit >180m
>250 f
622 ± 274 549 (246, 749) 30 562 ± 173 571 (428, 703) 24 t-test 0.33
Urine Ox <40 33.7 ± 13.3 31.2 (25.0, 40.6) 30 40.3 ± 16.0 38.3 (28.1, 49.3) 24 MW 0.09
CaOx SS 6–10 7.67 ± 3.67 8.3 (5.1, 9.5) 30 8.75 ± 3.64 8.2 (6.5, 10.5) 25 t-test 0.28
CaPhos SS 0.5–2 2.11 ± 1.29 2.4 (0.7, 3.1) 30 2.67 ± 1.55 2.5 (1.1, 3.8) 25 MW 0.12
Urine Sul 20–80 30.48 ± 10.65 32.77 (22.75, 37.87) 30 37.18 ± 15.32 35.4 (24.39, 48.57) 24 t-test 0.08
UUN 6–14 7.76 ± 2.43 8.03 (6.21, 9.06) 30 9.32 ± 3.73 8.23 (6.81, 11.32) 24 t-test 0.09
Urine PCR 8–14 0.97 ± 0.24 0.95 (0.82, 1.12) 30 1.18 ± 0.45 1.08 (0.83, 1.44) 25 MW 0.08
UA: pH 5–7.5 6.3 ± 0.9 6 (6, 7) 64 6.5 ± 1.1 6 (6, 7) 44 MW 0.34
UA: SG 1–1.035 1.019 ± 0.009 1.02 (1.01, 1.03) 66 1.022 ± 0.006 1.02 (1.02, 1.03) 46 t-test 0.07
Number % Number %
UA: +LE Neg 23 33 69 2 4 46 Fisher exact *<0.001
UA: +nit Neg 2 3 69 0 0 46 Fisher exact 0.52
UA: +hgb Neg 55 80 69 39 85 46 Fisher exact 0.48
UA: +prot Neg 33 48 69 20 43 46 Chi square 0.36
Results, Mean ± Std Dev for parametric and Median (25, 75%) for non-parametric data. Serum labs: Na+, K+, Cl−, CO2 presented as mEq/L; Ca
++, Phos, BUN, creatinine, and uric
acid presented as mg/dl; Vitamin D in ng/ml; PTH as pg/ml Urine labs: 24 h urine Ca++, Citrate, and oxalate presented as mg/kg/1.73 m2, Protein catabolic rate (PCR) presented as
g/kg/day and urine urea nitrogren (UUN) presented as g/1.73 m2/day. Urine sulfates presented as mEq/1.73/m2/day UA findings called positive if 1+ or greater. MW, Mann-Whitney.
Significant p-values are indicated in Bold. *Significant p-values.
affected children (7). However, very few patients were diagnosed
with monogenic stone disease or diseases which predispose to
stones such as RTA. These low rates are likely in part due to
the paucity of patients evaluated by nephrology and the few
patients who completed full metabolic work ups. In previous
pediatric studies 17–21% of stone forming children were found
to have a monogenic cause for stones. We speculate that a larger
percentage of our patients would have been diagnosed with
monogenic stones if a greater number of metabolic evaluations
were completed and genetic screening incorporated (19).
There were no significant differences between females and
males for common stone risk factors including urine calcium,
oxalate, citrate, calcium oxalate supersaturation, and calcium
phosphate supersaturation; this indicates that an unknown
risk factor is responsible for the female excess of pediatric
urinary stones.
We identified the novel and unexpected finding that females
had lower height z-scores (medians 0.2) than males (median 0.8).
Why stone forming females have lower height z-scores is unclear
but the transition of male predominance to female predominance
in stone forming children at the onset of puberty is intriguing.
Puberty is associated with increases in sex hormones (estrogens
and androgens), as well as changing growth hormone (GH) and
insulin-like growth factor-1 (IGF-1) levels; together this neuro-
endocrine axis controls linear growth, accumulation of muscle
mass, and bone mineralization (20). Previous studies have also
linked sex hormones to urinary citrate and calcium excretion.
Dey et al. (21) demonstrated that adult stone forming women had
alterations in urinary citrate and calcium excretion when they
reach menopause, and estrogen replacement therapy increases
citrate in adult female stone formers (22, 23). We speculate that
another possible explanation for lower female height z-score
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TABLE 4 | Percent of patients with metabolic findings.
Female Male Statistical test p-value
Patient # with
finding/# with
data on results available
% Patient # with
finding/# with
data on results available
%
Height z-score < −1 11/49 22 2/27 7 Fisher exact 0.12
Bicarbonate <22 meq/dl 11/58 19 12/43 28 Chi square 0.29
Calcium >10.5 mg/dl 1/60 2 0/42 0 Fisher exact 1.00
Vitamin D >50 ng/ml 0/10 0 1/13 8 Fisher exact 1.00
GFR <90 16/41 39 7/24 29 Chi square 0.46
GFR>140 4/41 10 2/24 8 Fisher exact 1.00
Hypercalciuria (>4 mg/kg/day) 5/30 17 6/24 25 Fisher exact 0.51
Hyperoxaluria (>40 mg/1.73 m2/day) 7/30 23 11/24 46 Fisher exact 0.15
Hypocitraturia (<180 mg/1.73 m2/day) 1/30 3 0/24 0 Chi square 1.00
FIGURE 1 | The correlations between height z-score with serum calcium (mg/dl) (left), serum bicarbonate (mEq/L) (middle), and eGFR (ml/min/1.73 m2) (right) for all
patients (top), females (middle), and males (bottom). There was no significant correlation for any of the comparisons. Sixty-four patients (43 females and 24 males) had
both a height z-score and serum calcium measured, 65 patients (41 females and 24 males) had both a height z-score and serum bicarbonate measured and 65 (41
females and 24 males) patients had both a height z-score and eGFR). Serum calcium in mg/dl, eGFR in mil/min/1.73 m2 and bicarbonate in mEq/L. The dashed lines
represent 95% confidence intervals.
includes the number of stone formers with identified chronic
diseases that could also affect height including Crohn’s disease
and CKD. Only one patient was formally diagnosed with renal
tubular acidosis (RTA), however, given the lack of standardized
work up in this cohort the existence of renal tubular acidosis
(RTA) or incomplete RTA in the female patients could contribute
to lower height z scores (24). The mean serum bicarbonate in
these patients was ∼24 mEq/L which is toward the lower end
of the normal range of 23–29 mEq/L. However, on additional
analysis the height z-score did not correlate with the serum
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FIGURE 2 | The correlations between eGFR with serum BUN/creatinine ratio (left) and serum bicarbonate (mEq/L) (right), for all patients (top), females (middle), and
males (bottom). eGFR had a significant direct correlation with the BUN/creatinine ratio for all patients, females, and males. There was no significant correlation
between the eGFR and serum bicarbonate. Sixty-five patients (41 males and 24 females) had both a height z-score and serum BUN/creatinine ratio measured and 63
patients (40 females and 23 males) had both an eGFR and serum bicarbonate. Serum BUN/creatinine in mg/mg, eGFR in mil/min/1.73 m2 and bicarbonate in mEq/L.
The dashed lines represent 95% confidence intervals.
bicarbonate in either males or female and the mean serum CO2
was not lower in female vs. male patients. Nonetheless 12/59
(21%) and 11/43 (26%) of female and male patients, respectively,
had a serum CO2 < 22 raising the possibility that some type of
mild acidosis is present in our cohort. Should our findings be
confirmed, additional studies should evaluate renal acidification
defects and growth rates. How sex, puberty, and growth all
interconnect is not clear and may be linked to renal acidification
defects; it is certainly an area deserving of increased research in
children and adults.
Our pediatric stone forming cohort also had a relatively
high incidence of skeletal fracture, with 15% of males and
12% of females having a documented skeletal fracture. On
review of secondary diagnoses we did find several diagnoses
that can be associated with skeletal fractures. For females
this included three patients with CKD, renal transplant, and
Topiramate use, respectively. Among stone forming males
with fractures four had comorbidities including one with an
extensive medical history of chromosomal abnormality and
Evan’s syndrome, another with polyarticular juvenile rheumatoid
arthritis, a third with arthritis and heavy steroid use and a
fourth with ulcerative colitis and heavy steroid use. Once these
patients were excluded there remained 8.5% of females and
7.4% of males with skeletal fracture who did not have any co-
morbid conditions associated with fracture; these findings are
consistent with previous reports of bone mineral density loss
in adults and children with stones as well as increased skeletal
fracture rates (25, 26). However, one could also argue that
children whose chronic diseases which predisposed them to bone
disease also predisposed them to high rates of kidney stones
formation similar to a previously identified pediatric cohort
which showed non-ambulation and use of lithogenic medications
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FIGURE 3 | The correlations between urine markers of dietary protein intake consisting of urine protein catabolic rate (PCR) (left), urine urea nitrogen (UUN) (middle),
and urine sulfate (SUL) (right), compared to eGFR (top), serum BUN (middle), and serum BUN/creatinine (bottom). The correlation between PCR and BUN just missed
significance while there was a significant correlation between UUN and eGFR along with SUL and eGFR.
to be frequent risk factors for concurrent stone and bone
disease (27).
Male urinary stone patients had a significantly higher
BUN/creatinine ratio than female patients which might indicate
that volume depletion and/or high protein intake is more
pronounced in boys. In support of this finding urine specific
gravity trended higher in male patients (p = 0.07). Low urine
volumes associated with poor hydration have previously been
reported to correlate with increased urine crystal supersaturation
and stone formation, but to our knowledge this study represents
the first sex based difference in hydration markers in a pediatric
urinary stone patient population (28). Although, the mean serum
estimated glomerular filtration rates (eGFRs) were within the
normal range of 90–120 ml/min/1.73 m2, one of the more
concerning findings in our studies was that 35 patients had
low eGFR (<90 ml/min/1.73 m2) and 9% had a eGFRs >140
m/min/1.73 m2 consistent with hyperfiltration. In our cohort
the most likely etiologies for this are high protein intake
and/or chronic dehydration, both which have been linked to
hyperfiltration and urinary stone disease (29–32). Ten of the
patients with a low eGFR had a concurrent diagnosis of CKD,
pyelonephritis, AKI, proteinuria, cystinuria and/or an elevated
creatinine. In addition, labs may have been obtained in the ED
during episodes of acute renal colic where patients are at risk
for AKI from dehydration and Non-steroidal anti-inflammatory
(NSAID) use. Due to the association of CKD and urinary
stones in adults (33, 34), it will be important to estimate eGFR,
even if the creatinine is in the “normal” range, and follow-
up for longitudinal eGFR monitoring. Also noteworthy is that
patient’s increasing BUN/creatinine ratios significantly correlated
with increasing eGFRs. While the BUN/creatinine ratio is
typically preserved during CKD progression and intrinsic AKI,
an increasing BUN/creatinine ratio indicates that the plasma urea
is increased relative to creatinine and is usually seen in the setting
of high protein dietary intake, catabolic states, gastrointestinal
bleeds, or decreased renal perfusion (35). A similar correlation
between the BUN/creatinine ratio and eGFR was noted in a
survey of children seen as outpatients in a Pediatric Nephrology
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TABLE 5 | Clinical course, procedures, and treatment.
Outcome Female (n = 82) Male (n = 54) P-value
Number % Number %
>1 stone episodes 19 23 11 20 0.69
Hospitalization 29 35 19 35 1.00
Multiple ED visits 14 17 14 26 0.21
≥1 procedure 17 21 8 15 0.38
Stent placement 8 10 1 2 0.09
Pyelogram 8 10 3 6 0.52
Lithotripsy 9 11 6 11 1.00
Ureteroscopy 9 11 3 6 0.36
Basket 4 5 1 2 0.35
Tamulosin prescription 38 46 22 41 0.60
Hydrochlorothiazide
prescription
2 2 3 6 0.39
Citrate prescription 6 7 4 7 1.00
Dietary
recommendations
55 67 40 74 0.38
↑ Fluids 55 67 39 72 0.52
↑ Dietary citrate 17 21 2 4 *0.01
↑ Dietary potassium 2 2 1 2 1.00
↓ Dietary sodium 22 27 15 28 0.92
↓ Dietary oxalate 3 4 4 7 0.43
*Precedes a significant p value; ↑ denotes increasing; ↓ denotes decreasing. Significant
p-values are indicated in Bold.
clinic; they noted a higher BUN/creatinine ratio in females where
ins our stone cohort males had a higher BUN/creatinine ratio
(36). Other markers for dietary protein intake including urine
urea nitrogen (UUN) and urine sulfate significantly correlated
with eGFR supporting a potential link between dietary protein
intake and hyperfiltration.
We also identified that female urinary stone patients were >8
times more likely to have leukocyte esterase (LE) on urinalysis
when compared to male urinary stone patients. We know that LE
is a non-specificmarker of white cells within the urine, most often
associated with urinary tract infections (UTIs). In Taiwan, 44%
of female urinary stone patients had a UTI history (37). Urine
cultures were not available and we were unable to differentiate
between an inflammatory or infectious state in these patients.
Urinary tract infections can occur as result of urinary stones
but also are a potential cause of stones (1). Pyelonephritis was
listed as a diagnosis for 6 females and 2 males in our cohort, 12
females had a history of UTI and one had a history of urosepsis.
Whether the high rate of pyuria is the result of acute UTIs, a more
chronic dysbiosis or inflammation from crystalluria remains to
be determined.
We were able to identify pediatric urinary stone practice
patterns at a single institution level. We noted management
similarities and difference between male and female patients.
24 h urine studies were not collected in all patients, and this
may reflect the preponderance of referrals to urology who
traditionally do fewer urinary assessments than the nephrology
group. However, for those patients that did have 24 h urine
studies we did not find difference between males and females
rates of low urine citrate, hypercalciuria, hyperoxaluria, or low
urine volume. CTs were obtained on 67% of male patients
and 57% of female patients, making limiting future radiation
exposure a priority (38). Nephrocalcinosis was noted in two
patients who were diagnosed with RTA and hypercalciuria
respectively; this was consistent with previous pediatric studies
(39, 40). Most patients had a basic metabolic profile with calcium
measured. However, phosphorous, magnesium, parathyroid
hormone, vitamin D, and uric acid were obtained in <25% of
patients limiting practitioners’ ability to diagnose rare disorders.
Despite a high risk of recurrent stones, <13% of patients
were treated with citrate and/or a thiazide diuretic to help
prevent future stones. Finally, no patients had a bone density
measured by dual energy X-ray absorptiometry (DXA) despite
a fracture history in 12% of the patients, and the known
association of urinary stones and low bone density (25, 41,
42). Indications for pharmacologic management and bone
mineral density screening of pediatric urinary stone patients
should be defined and would benefit from future randomized
controlled trials.
Limitations of this study include retrospective design and
that data collection was from a single tertiary care pediatric
hospital in the Midwest, and thus may limit generalizability.
Furthermore, the study lacks protocol standardization and
during the study period local nephrology and urology groups
differed greatly in their evaluation and treatment patterns; thus
only 20% of patients were evaluated by a nephrologist resulting
in few patients with a complete metabolic work up and few
monogenic stone formers were identified. This center now
has a multidisciplinary kidney stone clinic with standardized
evaluation protocol. This dataset will serve as a baseline for future
studies demonstrating differences in patient outcomes with and
without protocol standardization that incorporates evaluation
by a pediatric nephrologist. Additionally, we have added a sub-
analysis (see Figures 1, 2) of some of the key findings (low height
z-score and high BUN/creatinine ratio) limited to patients that
had components of the urinary stone evaluation completed to
identify potential associations. Due to the retrospective nature
of the study additional limitations include our reliance on
diagnostic codes recorded for billing to identify stone formers
and thus may have underestimated the true prevalence of stones.
Similarly our retrospective data collection information ensured
that data concerning patient ethnicity was not available and
made advanced analysis of the pyuria observed in our cohort
impossible. Urinary tract infections can be very difficult to
diagnose correctly in retrospective work due to frequent lack
of urine culture in clinical practice; thus correctly connecting
symptoms with urinalysis results to true infection without the
definitive assistance of a culture can be very difficult. Further,
to truly evaluate the meaning of a positive LE on urinalysis we
would also need urine microbiome results due to the expanding
body of research demonstrating the clinical importance of the
urine microbiome. Individual’s urine microbiome contains many
bacteria not culturable with standard clinical urine culture
techniques and thus a formal evaluation for “sterile” (culture
negative) pyuria—which is beyond the scope of this study- would
be necessary. Thus, we are limited to reporting that pyuria is
significantly more frequent in female vs. male pediatric stone
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formers. Almost all of our patients were within theWorld Health
Organization definition of the adolescent age range of 10–19
years (43), thus our findings might not be applicable to younger
children. Our small sample size relegates many of our findings
to hypothesis generating. However, this is the largest study to
evaluate stone forming children for sex specific characteristics
published to date that we were able to find.
In summary, this study provides preliminary evidence of
female vs. male specific differences in pediatric urinary stone
presentation, management, laboratory results, and outcomes.
Based on our results, follow-up studies to validate differential
height z-scores, increased urine LE in female urinary stone
patients, and increased rates of volume depletion markers
in male urinary stone patients are needed. We identified
that an increasing BUN/creatinine ratio is associated with
increasing eGFR and 9% of patients have labs consistent
with glomerular hyperfiltration. A high protein diet and/or
chronic hypohydration may be a mechanism, with an origin
in the pediatric age range, for the association between CKD
and urinary stone disease. Additionally, pediatric urinary
stone management would benefit from guidelines regarding
the indications for CT to limit radiation exposure, when
DXA scans are indicated, and consensus on when to initiate
pharmacological therapy.
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